History of risedronate
- 6 May 2020
- journal article
- research article
- Published by Elsevier BV in Bone
- Vol. 137, 115407
- https://doi.org/10.1016/j.bone.2020.115407
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- A Novel Monthly Dosing Regimen of Risedronate for the Treatment of Postmenopausal Osteoporosis: 2-Year DataCalcified Tissue International, 2012
- Efficacy and safety of risedronate 150-mg once a month in the treatment of postmenopausal osteoporosis: 2-year dataOsteoporosis International, 2012
- Effect of Stopping Risedronate after Long-Term Treatment on Bone TurnoverJournal of Clinical Endocrinology & Metabolism, 2011
- Efficacy and safety of a novel delayed-release risedronate 35 mg once-a-week tabletOsteoporosis International, 2011
- Inhibition of Geranylgeranyl Diphosphate Synthase by Bisphosphonates: A Crystallographic and Computational InvestigationJournal of Medicinal Chemistry, 2008
- The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugsProceedings of the National Academy of Sciences of the United States of America, 2006
- Comparison of a Single Infusion of Zoledronic Acid with Risedronate for Paget's DiseaseThe New England Journal of Medicine, 2005
- Dose‐Proportional Pharmacokinetics of Risedronate on Single‐Dose Oral Administration to Healthy VolunteersThe Journal of Clinical Pharmacology, 2000
- Vertebral fracture assessment using a semiquantitative techniqueJournal of Bone and Mineral Research, 1993
- Skeletal effects of withdrawal of estrogen and diphosphonate treatment in ovariectomized ratsCalcified Tissue International, 1993